Blog

Paolo Tarantino: St. Gallen Consensus 2025 – 10 key votes

Paolo Tarantino/X

Mar 24, 2025, 13:48

Paolo Tarantino: St. Gallen Consensus 2025 – 10 key votes

Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post on X:

“The 19th St. Gallen Conference took place this week in Vienna.

Nearly 80 expert panelists voted on key debated topics in breast oncology, selected by Harold J. Burstein & G Curigliano.

Here’s 10 key results from the SGBCC2025 consensus voting, divided by topic/breast cancer subtype.”

Paolo Tarantino: St. Gallen Consensus 2025 - 10 key votes

Rich Paxman, Chief Medical Officer and Managing Director at Paxman, reshared the post on X, adding:

“Delighted to see the consensus with regards to mitigating taxane-induced neuropathy (CIPN).

Looking forward to presenting further data later this year from Paxman in collaboration with NUS along with the ongoing SWOG Cancer Research Network trial ICECOMPRESS.”

Breast Cancer breast oncology cancer Dana-Farber Cancer Institute fight against cancer G Curigliano Global fight against cancer Harold J. Burstein ICECOMPRESS OncoDaily Oncology Paolo Tarantino paxman Rich Paxman SGBCC2025 St. Gallen Consensus SWOG Cancer Research Network taxane-induced neuropathy Vienna

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute